EMERGENT BIOSOLUTIONS INC. Disposal Group, Including Discontinued Operation, Liabilities, Current
EMERGENT BIOSOLUTIONS INC. (EBS) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $4.50 million as of 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2025-10-30
- 2025-09-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $4.50M.
- 2025-06-30: Disposal Group, Including Discontinued Operation, Liabilities, Current $4.70M.
- 2025-03-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $4.80M.
- 2024-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current |
|---|---|
| 2025-09-30 | $4.50M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $4.70M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.80M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-Q · filed 2025-10-30 |
| 2024-06-30 | $10.10M 10-Q · filed 2024-08-07 |
| 2023-12-31 | $0.00 10-Q · filed 2024-08-07 |
| 2023-03-31 | $37.50M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-10 |
| 2016-12-31 | $0.00 10-K · filed 2017-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 |
| 2015-12-31 | $17.35M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |